## EMN: Eastman Chemical Company - XLB: Basic Materials

### Executive Summary

STRENGTH thesis confirmed: MRS_10 at 3.7% in lower entry zone (3.0-6.0%), top quartile (85th pct) cross-sectional ranking. Short-term MRS_5 (0.1%) confirms momentum alignment.

- **Horizon:** 5-20 days (swing)
- **Risk Profile:** Moderate - momentum continuation
- **Stop Type:** Fixed 2xATR ($59.81)
- **If Wrong:** Exit if MRS_10 drops below entry zone or breaks stop
- **Invalidation:** MRS_10 exits entry zone or MRS_5 turns negative

### News

- **Articles:** 4
- **Sentiment:** Bullish (Bullish: 2, Bearish: 0)

**1. RBC Raises Price Target on Eastman Chemical to $74 From $71, Keeps Outperform Rating**
- Source: marketscreener.com | 20251216T123421 | Bullish | Relevance: 100%
- RBC has increased its price target for Eastman Chemical (EMN) to $74, up from $71, while maintaining an "Outperform" rating on the stock. This adjustment reflects continued confidence in the company's performance. The company also recently announced an increase in its quarterly dividend to $0.84 per share.

**2. Thrivent Financial for Lutherans Trims Stock Position in Eastman Chemical Company $EMN**
- Source: MarketBeat | 20251216T140751 | Somewhat-Bearish | Relevance: 100%
- Thrivent Financial for Lutherans significantly reduced its stake in Eastman Chemical Company (NYSE:EMN) by 39.9% in the second quarter, now holding 498,733 shares valued at approximately $37.24 million. This move comes as Eastman Chemical missed its quarterly earnings and revenue expectations, despite increasing its quarterly dividend to $0.84 per share. Various other institutional investors have recently adjusted their positions in the company, which maintains a "Moderate Buy" rating among analysts.

**3. Walnut Level Capital LLC Buys 47,946 Shares of Eastman Chemical Company $EMN**
- Source: MarketBeat | 20251214T134959 | Neutral | Relevance: 100%
- Walnut Level Capital LLC significantly increased its stake in Eastman Chemical (NYSE:EMN) by 111.2% in Q2, acquiring 47,946 additional shares to reach a total of 91,061 shares valued at approximately $6.80 million. This makes Eastman Chemical its 6th largest holding, representing about 3.7% of its portfolio. Concurrently, Eastman Chemical reported Q2 EPS of $1.14 due to revenues of $2.20 billion, missing analyst estimates, and announced an increase in its quarterly dividend to $0.84, resulting in an annualized yield of 5.1%.

**4. Eastman, AstraZeneca, Kraft Heinz, and P&G Recognized with OMP Supply Chain Awards**
- Source: ACN Newswire | 20251216T140756 | Bullish | Relevance: 100%
- AstraZeneca, Eastman, Kraft Heinz, and P&G were honored at the OMP Conference in Miami for their outstanding contributions and commitment to innovation and excellence in supply chain planning. Eastman received the Long-Term Partnership Award for co-shaping Unison Planning, AstraZeneca won the Innovation Award for AI-driven planning, and Kraft Heinz and P&G were recognized with the Excellence Award for their sustained commitment to advancing digital supply chain planning. Philip Vervloesem, OMP's Chief Commercial and Markets Officer, commended all the winners for their achievements.

### Insider Activity (90 days)

| Metric | Value |
|--------|-------|
| Direction | **NET_BUYING** |
| Buys | 11 ($0.08M) |
| Sells | 0 ($0.00M) |

### Institutional Ownership

| Metric | Value |
|--------|-------|
| Total Ownership | 46.1% |
| Smart Money | **BULLISH** |
| Net Flow | 0.0% |
| Buying/Selling | 4 / 6 |

**Top Holders:**
- Vanguard Group Inc: 12.6% (-2.2%)
- Blackrock Inc.: 7.0% (+0.9%)
- State Street Corpora: 5.0% (+24.3%)
- Capital Research Glo: 3.7% (-1.0%)
- Dimensional Fund Adv: 3.5% (+14.4%)

### Key Risks

1. Valuation risk: PEG 3.9x with declining EPS estimates leaves no margin for error.
2. Long-term trend broken: trading 12.1% below SMA200.
3. Market regime shift could impact momentum names disproportionately.

### Catalysts

- AI/machine learning initiatives could drive multiple expansion if executed.
- Broader market risk-on sentiment could lift quality names.

### Fundamentals

PEG ratio 3.87 signals overvaluation risk, limited margin of safety. Forward P/E 10.2x attractive for 14% earnings growth. Institutional flow bullish (4 buying vs 6 selling).

| Metric | Value |
|--------|-------|
| Market Cap | $7.3B |
| Beta | 1.25 |
| 52W Range | $56.11 - $103.82 |
| Short Interest | 4.3% |

| Valuation | Value |
|-----------|-------|
| PEG Ratio | 3.87 |
| Forward P/E | 10.2 |
| Current P/E | 11.6 |
| YoY Growth | 14.1% |
| EPS Direction | FALLING |

### Technicals

MRS_10 weakening modestly (-0.8% over 5 days). Currently in lower STRENGTH zone (3.0-6.0%), cross-sectional ranking at 85th percentile. MRS_5 at 0.1% confirms short-term momentum alignment. Below SMA200 (0.88x), long-term trend not supportive. RSI neutral at 56. OFD pattern: +DUN (Resistance).

| Metric | Value | Signal |
|--------|-------|--------|
| MRS_10 | 3.67% (CS: 86) | Strong |
| RSI_14 | 56.0 | Neutral |
| MACD Histogram | 0.44 | Bullish |
| vs SMA20 | 1.039x | Above |
| vs SMA50 | 1.042x | Above |
| vs SMA200 | 0.879x | Below |

### Decision

- **Verdict:** AVOID
- **Thesis:** STRENGTH

### Trade Setup

- **Entry:** $63.67
- **Stop Loss:** $59.81 (6.1% risk)
- **Target:** $69.46 (R:R method)
- **Risk/Reward:** 1.50:1
- **Target Reasoning:** STRENGTH thesis targets 1.5x risk/reward based on historical edge

### Position Sizing

- **Shares:** 310
- **Position Value:** $19,737.70
- **Portfolio %:** 19.74%
- **Risk Dollars:** $1,200.00
- **Risk Per Trade:** 1.20%
- **Modifiers:** L1 100% | L2 120% | Combined 1.20x

### Market Context

| Layer | Signal | Modifier |
|-------|--------|----------|
| L1 Macro | NORMAL (MEDIUM) | 1.00x |
| L2 Sector | TREND (Zone A) | 1.20x |

*NORMAL regime with balanced risk positioning. VIX remains calm at 16.48 while breadth shows modest improvement to 52%, indicating neither euphoria nor distress. Mixed sectoral themes from energy weakness to AI expansion suggest stock-picking environment rather than broad directional moves.*

### Earnings

**Next:** 2026-01-29 (Est: $0.81)

| Quarter | Est | Actual | Surprise |
|---------|-----|--------|----------|
| 2025Q3 | $1.17 | $1.14 | -2.2% |
| 2025Q2 | $1.75 | $1.60 | -8.7% |
| 2025Q1 | $1.89 | $1.91 | +1.2% |
| 2024Q4 | $1.57 | $1.87 | +18.9% |

---
*RULE-based L3 | 2026-01-06 16:37 | MRS_10*